CMPI - Checkmate Pharmaceuticals Inc
Close
10.5
0.020 0.190%
Share volume: 0
Last Updated: Fri 27 May 2022 10:00:00 PM CEST
PREVIOUS CLOSE
CHG
CHG%
$10.48
0.02
0.19%
Performance
5 Days
0 0%
1 Month
0 0%
3 Months
0 0%
6 Months
0 0%
1 Year
0 0%
2 Year
0 0%
Key data
Company detail
CEO:
Region: US
Website: checkmatepharma.com
Employees: 25
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:
Region: US
Website: checkmatepharma.com
Employees: 25
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:
Checkmate Pharmaceuticals, Inc. operates as a biotechnology company. The Company discovers and develops novel approaches for cancer immunotherapy such as immuno-oncology. Checkmate Pharmaceuticals serves patients worldwide.
Recent news